Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of Simotinib Hydrochloride in Healthy Subjects

NCT01469910 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Simotinib Hydrochloride
DRUG: Placebo

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.